T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: An important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells

Journal of Experimental Medicine

Volumn 179, Issue 4, 1994, Pages 1205-1214

  Ramarathinam, Lakshmi ^a   Castle, Madalyn ^a   Wu, Yan ^a   Liu, Yang ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CARCINOGENESIS; CARCINOGENIC ACTIVITY; EFFECTOR CELL; FLOW CYTOMETRY; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR REJECTION;

ANIMAL; ANTIGENS, CD27; ANTIGENS, CD8; ANTIGENS, CD80; CD4-POSITIVE T-LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0028343870     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.179.4.1205     Document Type: Article

References (48)

1. Greenberg, P.D. 1991. Adoptive T cell therapy of tumors: mechanism operative in the recognition and elimination of tumors. Adv. Immunol. 49:281.
2. Lafferty, K.J., S.J. Prowse, and C.J. Simeonovich. 1983. Immunobiology of tissue transplantation: a return to passenger leukocyte concept. Annu. Rev. Immunol. 1:143.
3. Jenkins, M.K., and R.H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp Med. 165: 302.
4. Liu, Y., and C.A. Janeway, Jr. 1990. Interferon y plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J. Exp Med. 172:1735.
5. Liu, Y., and P.S. Linsley. 1992. Costimulation of T cell growth. Curr. Opin. Immunol. 4:265.
6. Weaver, C.T., and E.R. Unanue. 1990. The costimulatory function of antigen-presenting cells. Immunol. Today. 11:49.
7. Janeway, C.A., Jr. 1992. The immune system is evolved to discriminate infectious nonself from noninfectious self. Immunol. Today. 13:11.
8. Restifo, N.P., F. Esquivel, A.L. Asher, H. Stotter, R.J. Barth, J.R. Bennink, J.J. Mulé, J.W. Yewdell, and S.A. Rosenberg. 1991. Defective presentation of endogenous antigens by murine sarcoma: implication for the failure of an anti-tumor immune response J Immunol. 147:1453.
9. + T cells against the wildtype tumor: correlation with antigen presentation capacity. J. Exp Med. 175:1423.
10. Talmadge, D.W., J.A. Woolnough, H. Hemmingsen, L. Lopez, and K.J. Lafferty. 1977. Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s). Proc Natl Acad. Set. USA. 74:4610.
11. Linsley, P.S., E.A. Clark, and J.A. Ledbetter. 1990. The T cell antigen, CD28, mediates adhesion with B cells by interacting with the activation antigen B7/BB1. Proc Natl. Acad. Sci. USA. 87:5031.
12. Linsley, P.S., W. Brady, L. Grosmaire, A. Aruffo, N.K. Damle, and J.A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp Med. 173:721.
13. Jenkins, M.K., P.S. Taylor, S.D. Norton, and K.B. Urdhl. 1991. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147:2461.
14. June, C.H., J.A. Ledbetter, P.S. Linsley, and C.B. Thompson. 1990. Role of CD28 in T cell activation. Immunol. Today. 11:211.
15. Harding, F.A., J.G. McArthur, J.A. Cross, D.H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling costimulates murine T cells and prevents induction of anergy in T cell clones. Nature (Lond.). 356:607.
16. Liu, Y., RA. Jones, W. Brady, C.A. Janeway, Jr., and P.S. Linsley. 1992. Costimulation of CD4 T cell growth: cooperation between B7 and the heat-stable antigen. Eur. J. Immunol. 22:2855.
17. Razi-Wolf, Z., G.J. Freeman, F. Galvin, B. Benacerraf, L. Nadler, and H. Reiser. 1992. Expression and function of the murine B7-antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc Natl. Acad. Sci. USA. 89:4210.
18. Tan, P., C. Anasetti, J.A. Hansen, J. Melrose, M. Brunvand, J. Bradshaw, J.A. Ledbetter, and P.S. Linsley. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp Med. 177:165.
19. Lenschow, D.J., Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, P.S. Linsley, and J.A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science (Wash. DC). 257:789.
20. Turka, A., P.S. Linsley, H. Lin, W. Brady, J.M. Leiden, R.-Q. Wei, M.L. Gibson, X.-G. Zheng, S. Myrdal, D. Gordon, T. Bailey, S.F. Bolling, and C. Thompson. 1992. T-cell activation by CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA. 89:11102.
21. + T cells. J. Exp Med. 173:759.
22. Chen, L.P., S. Ashe, W.A. Brady, I. Hellstrom, K.E. Hellstrom, J.A. Ledbetter, P. McGowan, and P.S. Linsley. 1992. Costimulation of anti-tumor immunity by the B7 counter receptor for the T lymphocyte molecules CD28 and CTLA4. Cell. 71:1093.
23. + T cells by B7-transfected melanoma cells. Science (Wash. DC). 259:368.
24. Baskar, S., S. Ostrand-Rosenberg, N. Nabavi, and L. Glimcher. 1993. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated MHC class II molecules. Proc. Natl. Acad. Sci. USA. 90:7015.
25. Wu, Y., Y. Guo, and Y. Liu. 1993. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7. J. Exp Med. 178:1789.
26. Razi-Wolf, Z., GJ. Freeman, F. Galvin, B. Benacerraf, L. Nadler, and H. Reiser. 1992. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA. 89:4210.
27. Dumont, F.J., R.C. Habbrtsett, L.C. Coker, E.A. Nichols, and E.A. Treffinger. 1985. High level expression of the plasma cell antigen PC.l on the T cell subset expanding in MRX/MpJ-Ipr/lpr mice: detection with a xenogeneic monoclonal antibody and alio antisera. Cell. Immunol. 96:327.
28. Sanchez-Madrid, F., P. Simon, S. Thompson, and T.A. Springer. 1983. Mapping of antigenic and functional epitopes on the a- and β-subunits of two related mouse glycoproteins involved in cell interaction, LFA-1 and Mac-1. J. Exp Med. 158:586.
29. Ozato, Y., Y.-J. Wan, and B. Orrison. 1985. Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in early stage embryos by interferon. Proc. Natl. Acad. Sci. USA. 82:2427.
30. Happier, J.W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted interleukin 2-producing T cell hybridomas: lack of independent H-2 and antigen recognition. J. Exp Med. 153:1198.
31. Pullen, A., P. Marrack, andj. Happier. 1988. The T cell repertoire is heavily influenced by tolerance to polymorphic self antigens. Nature (Lond.). 335:796.
32. Kanagawa, O., E. Palmer, and J. Bill. 1989. The T cell receptor αβ6 domain imparts reactivity to Mlsla antigen. Cell. Immunol. 119:412.
33. Okada, C., B. Halzmann, C. Guidos, E. Palmer, and I. Weiss-man. 1990. Characterization of a rat monoclonal antibody specific for a determinant encoded by the αβ7 gene segment. J. Immunol. 144:3473.
34. Staerz, V., H. Rammansee, J. Benedetto, and M. Bevan. 1985. Characterization of a murine monoclonal antibody specific for an allotypic determinant of the T cell receptor. J. Immunol. 134:3994.
35. Bill, J., O. Kanagawa, D.L. Woodland, and E. Palmer. 1989. The MHC molecule I-E is necessary but not sufficient for clonal deletion of αβll-bearing T cells. J. Exp Med. 169:1405.
36. + T cells expressing αβ11 to respond to I-E alloantigens in vivo. J. Exp Med. 170:1947.
37. +T cells.J. Exp Med. 170:135.
38. Dialynas, D.P., Z.S. Quan, K.A. Wall, A. Pieres, J. Quantans, M. Pieres, and F.W. Fitch. 1983. Characterization of murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity to human Leu3/T3 molecule. J. Immunol. 131:2445.
39. Ledbetter, J., R. Rouse, S. Micklem, andL. Herzenberg. 1980. T cell subsets defined by expression of Lyt-1, 2, 3 and Thy 1 antigen. J. Exp Med. 152:280.
40. Sarmiento, M., A.L. Glasebrook, and F.W. Fitch. 1985. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt-2 antigen block T cell mediated cytolysis in the absence of complement J Immunol. 125:2665.
41. Liu, Y., and A. Miillbacher. 1989. Activated B cell can replace CD4 T cells in providing immunological help for CD8 T cells. Proc. Natl. Acad. Sci. USA. 86:4629.
42. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp Med. 177:1791.
43. Azuma, M., M. Cayabayab, D. Buck, J.H. Philips, and L.L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp Med. 175:353.
44. Azuma, M., M. Cayabayab, J.H. Philips, and L.L. Lanier. 1993. Requirement of CD28-dependent T-cell mediated cytotoxicity. J. Immunol. 150:2091.
45. Ceredig, R., J.E. Allan, Z. Tabi, F. Lynch, and P.C. Doherty. 1987. Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis. J. Exp Med. 165:1539.
46. Liu, Y., R.V. Blanden, and A. Miillbacher. 1989. Identification of cytolytic lymphocytes in West Nile virus-infected central nervous system. J. Gen. Virol. 70:565.
47. Allen, J.E., J.E. Dixon, and P.C. Doherty. 1987. Nature of the inflammatory responses in the central nervous system of mice infected with lymphocytic choriomeningitis virus. Curr. Top Microbiol. Immunol. 134:131.
48. lanaka, Y., D. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T cell adhesion induced by proteoglycan-immobilized cytokine-1β. Nature (Lond.). 361:79.